28 May 2020
Posted in Pharma
Healthcare sector witnessed marginal growth in deal activity during week ended May 24
The number of deals announced in the global healthcare sector grew by 0.6% during the week ended May 24, 2020 compared to the previous week, according to GlobalData’s deals database.
Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Although the healthcare sector has been relatively resilient compared to other sectors amid uncertainty and volatile market conditions due to the COVID-19 outbreak, deal activity in the sector has been inconsistent during the last few weeks. The growth in deal activity during this week followed a decline in the previous week.”
Deal activity has remained inconsistent across geographies since the COVID-19 outbreak. While deal activity increased in key markets such as the US and the UK during the week ended May 24, 2020 compared to the previous week, China and Canada witnessed decline.
Mergers and acquisitions (M&A), equity offerings and venture financing deals volume increased by 6.3%, 10% and 54.5%, respectively, during the week ended May 24, 2020 compared to the previous week, while the number of partnership, private equity and licensing agreement deals declined by 6.9%, 45.5% and 40.9%.